114 research outputs found
An Automatic System for Dementia Detection using Acoustic and Linguistic Features
Early diagnosis of dementia is crucial for mitigating the consequences of this disease in patients. Previous studies have demonstrated that it is possible to detect the symptoms of dementia, in some cases even years before the onset of the disease, by detecting neurodegeneration-associated characteristics in a personâs speech. This paper presents an automatic method for detecting dementia caused by Alzheimerâs disease (AD) through a wide range of acoustic and linguistic features extracted
from the personâs speech. Two well-known databases containing speech for patients with AD and healthy controls are used to this end: DementiaBank and ADReSS. The experimental results show that our system is able to achieve state-of-theart performance on both databases. Furthermore, our results also show that the linguistic features extracted from the speech transcription are significantly better for detecting dementia.This work was funded by the Spanish State Research Agency (SRA) under the grant PID2019-108040RBC22/
SRA/10.13039/501100011033. Jose A. Gonzalez-Lopez holds a Juan de la Cierva-Incorporation Fellowship from the Spanish Ministry
of Science, Innovation and Universities (IJCI-2017-32926)
Transposon insertion in the purL gene induces biofilm depletion in Escherichia coli ATCC 25922
Current Escherichia coli antibiofilm treatments comprise a combination of antibiotics commonly used against planktonic cells, leading to treatment failure. A better understanding of the genes involved in biofilm formation could facilitate the development of efficient and specific new antibiofilm treatments. A total of 2578 E. coli mutants were generated by transposon insertion, of which 536 were analysed in this study. After sequencing, Tn263 mutant, classified as low biofilm-former (LF) compared to the wild-type (wt) strain (ATCC 25922), showed an interruption in the purL gene, involved in the de novo purine biosynthesis pathway. To elucidate the role of purL in biofilm formation, a knockout was generated showing reduced production of curli fibres, leading to an impaired biofilm formation. These conditions were restored by complementation of the strain or addition of exogenous inosine. Proteomic and transcriptional analyses were performed to characterise the differences caused by purL alterations. Thirteen proteins were altered compared to wt. The corresponding genes were analysed by qRT-PCR not only in the Tn263 and wt, but also in clinical strains with different biofilm activity. Overall, this study suggests that purL is essential for biofilm formation in E. coli and can be considered as a potential antibiofilm target
Affective Valence Detection from EEG Signals Using Wrapper Methods
In this work, a novel valence recognition system applied to EEG signals is presented. It consists of a feature extraction block followed by a wrapper classification algorithm. The proposed feature extraction method is based on measures of relative energies computed in shortâtime intervals and certain frequency bands of EEG signal segments timeâlocked to the stimuli presentation. These measures represent eventârelated desynchronization/synchronization of underlying brain neural networks. The subsequent feature selection and classification steps comprise a wrapper technique based on two different classification approaches: an ensemble classifier, i.e., a random forest of classification trees and a support vector machine algorithm. Applying a proper importance measure from the classifiers, the feature elimination has been used to identify the most relevant features of the decision making both for intrasubject and intersubject settings, using single trial signals and ensemble averaged signals, respectively. The proposed methodologies allowed us to identify a frontal region and a beta band as the most relevant characteristics, extracted from the electrical brain activity, in order to determine the affective valence elicited by visual stimuli
A Rat Immobilization Model Based on Cage Volume Reduction: A Physiological Model for Bed Rest?
Bed rest has been an established treatment in the past prescribed for critically illness or convalescing patients, in order to preserve their body metabolic resource, to prevent serious complications and to support their rapid path to recovery. However, it has been reported that prolonged bed rest can have detrimental consequences that may delay or prevent the recovery from clinical illness. In order to study disuse-induced changes in muscle and bone, as observed during prolonged bed rest in humans, an innovative new model of muscle disuse for rodents is presented. Basically, the animals are confined to a reduced space designed to restrict their locomotion movements and allow them to drink and eat easily, without generating physical stress. The animals were immobilized for either 7, 14, or 28 days. The immobilization procedure induced a significant decrease of food intake, both at 14 and 28 days of immobilization. The reduced food intake was not a consequence of a stress condition induced by the model since plasma corticosterone levels âan indicator of a stress responseâ were not altered following the immobilization period. The animals showed a significant decrease in soleus muscle mass, grip force and cross-sectional area (a measure of fiber size), together with a decrease in bone mineral density. The present model may potentially serve to investigate the effects of bed-rest in pathological states characterized by a catabolic condition, such as diabetes or cancer
Immobilization in diabetic rats results in altered glucose tolerance A model of reduced locomotion/activity in diabetes
TrainingâonâaâChip: A MultiâOrgan Device to Study the Effect of Muscle Exercise on Insulin Secretion in Vitro
Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents
This is the peer reviewed version of the following article: Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents. Journal of Gastroenterology and Hepatology (2020): 29 April, which has been published in final form at https://doi.org/10.1111/jgh.15084. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived VersionsBiological therapies may be changing the natural history of inflammatory bowel diseases, reducing the need for surgical intervention. We aimed to assess whether the availability of antiâTNF agents impacts the need for early surgery in Crohn's disease (CD) and ulcerative colitis (UC).
Methods
Retrospective, cohort study of patients diagnosed within a 6âyear period before and after the licensing of antiâTNFs (1990â1995 and 2007â2012 for CD; 1995â2000 and 2007â2012 for UC) were identified in the ENEIDA Registry. Surgeryâfree survival curves were compared between cohorts.
Results
A total of 7,370 CD patients (2,022 in Cohort 1 and 5,348 in Cohort 2) and 8,069 UC patients (2,938 in Cohort 1 and 5,131 in Cohort 2) were included. Immunosuppressants were used significantly earlier and more frequently in both CD and UC postâbiological cohorts. The cumulative probability of surgery was lower in CD following antiâTNF approval (16% and 11%, 22% and 16%, and 29% and 19%, at 1, 3 and 5 years, respectively p<0.0001), though not in UC (3% and 2%, 4% and 4%, and 6% and 5% at 1, 3 and 5 years, respectively; p=0.2). Ileal involvement, older age at diagnosis and active smoking in CD, and extensive disease in UC, were independent risk factors for surgery, whereas highâvolume IBD centres (in both CD and UC) and immunosuppressant use (in CD) were protective factors.
Conclusions
AntiâTNF availability was associated with a reduction in early surgery for CD (driven mainly by earlier and more widespread immunosuppressant use) but not in U
Prediction of poor outcome in clostridioides difficile infection: A multicentre external validation of the toxin B amplification cycle
ProducciĂłn CientĂficaClassification of patients according to their risk of poor outcomes in Clostridioides difficile infection (CDI) would enable implementation of costly new treatment options in a subset of patients at higher risk of poor outcome. In a previous study, we found that low toxin B amplification cycle thresholds (Ct) were independently associated with poor outcome CDI. Our objective was to perform a multicentre external validation of a PCR-toxin B Ct as a marker of poor outcome CDI. We carried out a multicentre study (14 hospitals) in which the characteristics and outcome of patients with CDI were evaluated. A subanalysis of the results of the amplification curve of real-time PCR gene toxin B (XpertTM C. difficile) was performed. A total of 223 patients were included. The median age was 73.0 years, 50.2% were female, and the median Charlson index was 3.0. The comparison of poor outcome and nonâpoor outcome CDI episodes revealed, respectively, the following results: median age (years), 77.0 vs 72.0 (pâŻ=âŻ0.009); patients from nursing homes, 24.4% vs 10.8% (pâŻ=âŻ0.039); median leukocytes (cells/ÎŒl), 10,740.0 vs 8795.0 (pâŻ=âŻ0.026); and median PCR-toxin B Ct, 23.3 vs 25.4 (pâŻ=âŻ0.004). Multivariate analysis showed that a PCR-toxin B Ct cut-off <23.5 was significantly and independently associated with poor outcome CDI (pâŻ=âŻ0.002; OR, 3.371; 95%CI, 1.565â7.264). This variable correctly classified 68.5% of patients. The use of this microbiological marker could facilitate early selection of patients who are at higher risk of poor outcome and are more likely to benefit from newer and more costly therapeutic options
Measurement of relative branching fractions of B decays to Ï(2S) and J/Ï mesons
The relative rates of B-meson decays into J/Ï and Ï(2S) mesons are measured for the three decay modes in pp collisions recorded with the LHCb detector. The ratios of branching fractions ( B) are measured to be where the third uncertainty is from the ratio of the Ï(2S) and J/Ï branching fractions to ÎŒ + ÎŒ â
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks : The GR@ACE project
Introduction: Large variability among Alzheimer's disease (AD) cases might impact genetic discoveries and complicate dissection of underlying biological pathways. Methods: Genome Research at Fundacio ACE (GR@ACE) is a genome-wide study of dementia and its clinical endophenotypes, defined based on AD's clinical certainty and vascular burden. We assessed the impact of known AD loci across endophenotypes to generate loci categories. We incorporated gene coexpression data and conducted pathway analysis per category. Finally, to evaluate the effect of heterogeneity in genetic studies, GR@ACE series were meta-analyzed with additional genome-wide association study data sets. Results: We classified known AD loci into three categories, which might reflect the disease clinical heterogeneity. Vascular processes were only detected as a causal mechanism in probable AD. The meta-analysis strategy revealed the ANKRD31-rs4704171 and NDUFAF6-rs10098778 and confirmed SCIMP-rs7225151 and CD33-rs3865444. Discussion: The regulation of vasculature is a prominent causal component of probable AD. GR@ACE meta-analysis revealed novel AD genetic signals, strongly driven by the presence of clinical heterogeneity in the AD series
- âŠ